The Nitric Oxide (NO) Donor Sodium Nitroprusside (SNP) and Its Potential for the Schizophrenia Therapy: Lights and Shadows

Schizophrenia is a severe psychiatric disorder affecting up to 1% of the worldwide population. Available therapy presents different limits comprising lack of efficiency in attenuating negative symptoms and cognitive deficits, typical features of schizophrenia and severe side effects. There is pressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zoupa, Elli, Pitsikas, Nikolaos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199342/
https://www.ncbi.nlm.nih.gov/pubmed/34073534
http://dx.doi.org/10.3390/molecules26113196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199342/
https://www.ncbi.nlm.nih.gov/pubmed/34073534
http://dx.doi.org/10.3390/molecules26113196

Ejemplares similares